You searched for "selection"

965 results found

Trials offering cytoreductive surgery for men with de novo synchronous metastatic prostate cancer

Life expectancy in men diagnosed with de novo synchronous metastatic hormone-sensitive prostate cancer (mHSPC) has risen to a median of 4.8 years with upfront systemic agents (such as docetaxel) in addition to standard androgen deprivation therapy (ADT) [1-3]. Within this...

BAUS 2023 Annual Scientific Meeting

BAUS June 2022 was certainly noteworthy for me personally, as Tim O’Brien passed on the baton of Presidency. It was also a very special meeting for everyone who participated. The event felt so refreshing after two years of COVID and...

Supporting chronic cystitis patients through the winter

The current pandemic is causing severe disruption to the care of patients with non-life-threatening conditions.

What are the long-term outcomes of TOT and TVT procedures?

This is a systematic review between 2000 and 2016 evaluating the efficacy and safety of midurethral sling (MUS) procedures in women. Studies were included if the follow-up data was five years or more. Objective cure rates showed no significant difference...

Campbell Walsh Wein Urology: 3-Volume Set (Campbell-Walsh Urology), 12th Edition

The 12th edition of the ‘Bible of Urology’ was a pleasure to review. The title has been changed to Campbell-Walsh-Wein Urology to honour Dr Alan Wein’s many years of dedicated chief editorship of this famous textbook. The current editor-in-chief, Alan...

ABC UK announces 2025 Nurse of the Year – Kathryn Chatterton

Action Bladder Cancer UK (ABC UK) is delighted to announce that the winner of the 2025 ABC UK Nurse of the Year award is Kathryn Chatterton, Bladder Cancer Advanced Nurse Practitioner / Cancer Nurse Specialist at Guy’s and St Thomas’...

Demanding cases or nightmares in endourology? May/Jun 2016

In the third article in this series the authors describe their experience with the very rare indications for laparoscopic stone surgery. Case 1 A 44-year-old woman presented with several months of malaise and right flank pain. A CT scan demonstrated...

Femeda Ltd Wins Prestigious Medilink Partnership with Academia Award

Partnership with Academia Award Winner: Femeda Ltd Femeda has committed to the first real world clinical trial for a consumer medical device globally to be run in Manchester. Femeda is extending the partnership with engagement of Phd students from the...

Femeda Ltd Wins Prestigious Medilink Partnership with Academia Award

Femeda has committed to the first real world clinical trial for a consumer medical device globally to be run in Manchester. Femeda is extending the partnership with engagement of Phd students from...

Urology patient assessment – importance of holistic approach – new paradigm

Mild cognitive impairment (MCI) seems to affect 30% of the general population above 65 and its presence has a wide range of significance. This is a prospective single centre study to look at MCI in adult urological patients above 18...

Prostate cancer: Black men more likely to be diagnosed at later stages

Latest data shows Black men have higher rates of stage 3 or stage 4 prostate cancer diagnoses compared with white men. Black men diagnosed at a later stage in their 60s are 14% less likely to get NICE approved treatment...

Femeda commence innovative real world clinical trial for Pelviva

A major 330 patient randomised ‘real world’ clinical trial has commenced for Pelviva in conjunction with the University of Manchester and South Manchester GP federation. The trial will compare Pelviva against...